By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Juvenile Diabetes Research Foundation 

26 Broadway
14th Floor
New York  New York  10004  U.S.A.
Phone: 212-479-7571 or 800-533-CURE Fax: n/a


Company News
JDRF And ViaCyte Announce Support For Development Of PEC-Direct Cell Replacement Therapy For Type 1 Diabetes 5/22/2017 10:30:58 AM
JDRF Release: New Research Identifies Novel Target For Controlling Immune Response To Implanted Materials 3/21/2017 6:37:22 AM
GluSense Ltd. Receives Investment From JDRF T1D Fund 2/16/2017 10:49:01 AM
JDRF Launches Early-Stage Investment Fund To Catalyze Development Of Commercial Type 1 Diabetes Therapies 1/26/2017 1:35:52 PM
Lexicon Pharma (LXRX) Reports Top-Line Results From Phase 2 Clinical Trial Conducted In Collaboration With Juvenile Diabetes Research Foundation 12/6/2016 6:34:42 AM
Becton, Dickinson and Company (BDX) Collaborates With Juvenile Diabetes Research Foundation To Focus On Extended Wear Innovations For Insulin Infusion Delivery 11/11/2016 1:10:43 PM
Juvenile Diabetes Research Foundation Celebrates FDA Approval of Artificial Pancreas System 9/29/2016 6:52:05 AM
AnTolRx Announces Series A Equity Funding From Pfizer (PFE), Juvenile Diabetes Research Foundation And Orion Equity Partners To Develop Targeted Nanoparticle Tolerance Therapeutics 9/8/2016 9:44:19 AM
Capillary Biomedical Developing Improved Insulin Delivery Catheter With Funding Support From Juvenile Diabetes Research Foundation 8/3/2016 11:03:35 AM
Infant Colds, Infections And Type 1 Diabetes Risk, Juvenile Diabetes Research Foundation Study 5/5/2016 6:57:25 AM